PPHvsETF 2ETF Comparison
VS
Choose a second ETF to run a side-by-side ETF comparison with PPH, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
PPH performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/23/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PPH ETF 2 | +4.67%– | +4.95%– | +13.41%– | +26.91%– | +57.53%– | +69.99%– |
| Flows | PPH ETF 2 | +$15M– | +$61M– | -$316M– | -$397M– | +$356M– | +$450M– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PPH ETF 2 | +19.86%– | +18.46%– | +16.43%– | +15.78%– |
| Max drawdown | PPH ETF 2 | -8.47%– | -10.78%– | -17.98%– | -20.19%– |
| Max drawdown duration | PPH ETF 2 | 59d– | 122d– | 434d– | 484d– |
Trading data
PPH | ETF 2 | |
Last sale 10/23/2026 at 1:30 PM | $114.93 | – |
| Previous close 10/22/2026 | $117.04 | – |
| Consolidated volume 10/22/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of September 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
PPH | ETF 2 | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 10/23/2026 at 1:30 PM
Live
Closed
PPH | ETF 2 | |
|---|---|---|
| Last price | $114.93 | – |
| 1D performance | -1.80% | – |
| AuM | $1.06 B | – |
| E/R | 0.36% | – |
Characteristics
PPH | ETF 2 | |
|---|---|---|
| Management strategy | Passive | – |
| Provider | VanEck | – |
| Benchmark | MVIS US Listed Pharmaceutical 25 Index | – |
| N° of holdings | 25 | – |
| Asset class | Equities | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 20, 2011 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
PPH
USA
62.46%
United Kingdom
10.95%
Switzerland
10.06%
Other
16.53%
ETF 2
Sectors
PPH
Healthcare
100%
Other
0%
ETF 2
Advertisement
Diversification
PPH
Total weight of top 15 holdings out of 15
90.56%
ETF 2
–
Top 15 holdings
Data as of August 31, 2026
PPH
Eli Lilly & Co.
19.11%
Merck & Co., Inc.
10.96%
Novartis AG
10.06%
Pfizer Inc.
5.05%
Bristol Myers Squibb Co.
4.98%
Novo Nordisk A/S
4.92%
McKesson Corp.
4.70%
AbbVie, Inc.
4.48%
Johnson & Johnson
4.43%
GSK Plc
4.13%
Sanofi
4.06%
Cencora, Inc.
3.68%
AstraZeneca PLC
3.59%
Haleon Plc
3.23%
Teva Pharmaceutical Industries Ltd.
3.17%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Latest news about PPH
Healthcare Stocks Rebound
August 14, 2023
PPH
Investing in the Aging Population: A Look at Bonds and Pharma ETFs
March 27, 2023
PPH
Trending sub-sectors in 2022
July 12, 2022
PPH
Advertisement
Advertisement
